ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.

February 25, 2000

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

ECOG, ACRIN Agree To Join; NCI’s Goal Of Four Adult Groups Is One Merger Away

March 18, 2011

HHA “Investigative Memorandum” Revives Controversy Over AIDS Virus, Royalties

July 1, 1994